Clinical trial
Treatment and Diagnosis of Plague
NCT00128466 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00128466 |
|---|---|
| Title | Treatment and Diagnosis of Plague |
| Official title | Safety and Efficacy of Gentamicin Versus Streptomycin for the Treatment of Naturally Occurring Human Plague and Evaluation of Rapid Diagnostic Test Kits for Yersinia Pestis |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Food and Drug Administration (FDA) U.S. Fed Ministry of Health, Madagascar Ministry of Health, Uganda |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Plague |
| Intervention type | Drug |
| Interventions | gentamicin, streptomycin |
| Enrollment | 114 |
| Start date | Aug 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Aug 10, 2005 |
| Last update posted | Feb 26, 2009 |
| Countries | Madagascar |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: